Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice

Neuroscience

Volumn 308, Issue , 2015, Pages 157-168

  Chen, H ^a   Sun, Y ^a,b   Lai, L ^a   Wu, H ^a   Xiao, Y ^a   Ming, B ^a   Gao, M ^a   Zou, H ^a   Xiong, P ^a   Xu, Y ^a   Tan, Z ^a   Gong, F ^a   Zheng, F ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Astrocyte; Central nervous system; Experimental autoimmune encephalomyelitis; Interleukin 33; Neuron

Indexed keywords

INTERLEUKIN 33; INTERLEUKIN RECEPTOR; INTERLEUKIN RECEPTOR ST2; UNCLASSIFIED DRUG; IL1RL1 PROTEIN, MOUSE; IL33 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOCRINE EFFECT; BRAIN NERVE CELL; CELL ACTIVATION; CELL DAMAGE; CELLULAR SECRETION; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TARGETING; SPINAL CORD; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; CELL NUCLEUS; CHRONIC DISEASE; CYTOPLASM; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; NERVE CELL; PATHOLOGY; SECRETION (PROCESS); WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CEREBRAL CORTEX; CHRONIC DISEASE; CYTOPLASM; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-33; MICE, INBRED C57BL; NEURONS; RECEPTORS, INTERLEUKIN; SPINAL CORD;

EID: 84942245080     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.09.019     Document Type: Article

References (48)

1. Ajami B., Bennett J.L., Krieger C., McNagny K.M., Rossi F.M. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 2011, 14:1142-1149.
2. Bourgeois E., Van L.P., Samson M., Diem S., Barra A., Roga S., Gombert J.M., Schneider E., Dy M., Gourdy P., Girard J.P., Herbelin A. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 2009, 39:1046-1055.
3. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., Bouche G., Girard J.P. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 2007, 104:282-287.
4. Chang Y.J., Kim H.Y., Albacker L.A., Baumgarth N., McKenzie A.N., Smith D.E., Dekruyff R.H., Umetsu D.T. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011, 12:631-638.
5. Chong W.P., Ling M.T., Liu Y., Caspi R.R., Wong W.M., Wu W., Tu W., Lau Y.L. Essential role of NK cells in IgG therapy for experimental autoimmune encephalomyelitis. PLoS One 2013, 8:e60862.
6. Christophi G.P., Gruber R.C., Panos M., Christophi R.L., Jubelt B., Massa P.T. Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol 2012, 142:308-319.
7. Davalos D., Ryu J.K., Merlini M., Baeten K.M., Le Moan N., Petersen M.A., Deerinck T.J., Smirnoff D.S., Bedard C., Hakozaki H., Gonias Murray S., Ling J.B., Lassmann H., Degen J.L., Ellisman M.H., Akassoglou K. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun 2012, 3:1227.
8. Du W.Y., Chen C.W., Lin F.K., Chuang C.C. IL-33 mediates the expressions of IL-5 and IL-13 in Angiostrongylus cantonensis-infected mice. Exp Parasitol 2013, 135:587-594.
9. Duan L., Chen J., Zhang H., Yang H., Zhu P., Xiong A., Xia Q., Zheng F., Tan Z., Gong F., Fang M. Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3(+) regulatory T-cell responses in mice. Mol Med 2012, 18:753-761.
10. Gadani S.P., Walsh J.T., Smirnov I., Zheng J., Kipnis J. The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 2015, 85:703-709.
11. Giulian D., Baker T.J., Shih L.C., Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986, 164:594-604.
12. Guabiraba R., Besnard A.G., Menezes G.B., Secher T., Jabir M.S., Amaral S.S., Braun H., Lima-Junior R.C., Ribeiro R.A., Cunha F.Q., Teixeira M.M., Beyaert R., Graham G.J., Liew F.Y. IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice. Mucosal Immunol 2014, 7:1079-1093.
13. Hidaka Y., Inaba Y., Matsuda K., Itoh M., Kaneyama T., Nakazawa Y., Koh C.S., Ichikawa M. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-gamma and TNF-alpha are important participants in the first attack but not in the relapse. J Neurol Sci 2014, 340:117-122.
14. Hsu D.S., Wang H.J., Tai S.K., Chou C.H., Hsieh C.H., Chiu P.H., Chen N.J., Yang M.H. Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages. Cancer Cell 2014, 26:534-548.
15. Hudson C.A., Christophi G.P., Gruber R.C., Wilmore J.R., Lawrence D.A., Massa P.T. Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 2008, 84:631-643.
16. Jiang H.R., Milovanovic M., Allan D., Niedbala W., Besnard A.G., Fukada S.Y., Alves-Filho J.C., Togbe D., Goodyear C.S., Linington C., Xu D., Lukic M.L., Liew F.Y. IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages. Eur J Immunol 2012, 42:1804-1814.
17. Jorgensen S.H., Jensen P.E., Laursen H., Sorensen P.S. Intravenous immunoglobulin ameliorates experimental autoimmune encephalomyelitis and reduces neuropathological abnormalities when administered prophylactically. Neurol Res 2005, 27:591-597.
18. Kakkar R., Hei H., Dobner S., Lee R.T. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 2012, 287:6941-6948.
19. Kempuraj D., Khan M.M., Thangavel R., Xiong Z., Yang E., Zaheer A. Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases. J Neuroimmune Pharmacol 2013, 8:643-650.
20. Kurowska-Stolarska M., Kewin P., Murphy G., Russo R.C., Stolarski B., Garcia C.C., Komai-Koma M., Pitman N., Li Y., Niedbala W., McKenzie A.N., Teixeira M.M., Liew F.Y., Xu D. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008, 181:4780-4790.
21. Lees J.R., Golumbek P.T., Sim J., Dorsey D., Russell J.H. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J Exp Med 2008, 205:2633-2642.
22. Li M., Li Y., Liu X., Gao X., Wang Y. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. J Neuroimmunol 2012, 247:25-31.
23. Liu C., Wang H.C., Yu S., Jin R., Tang H., Liu Y.F., Ge Q., Sun X.H., Zhang Y. Id1 expression promotes T regulatory cell differentiation by facilitating TCR costimulation. J Immunol 2014, 193:663-672.
24. Luthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., Brumatti G., Taylor R.C., Kersse K., Vandenabeele P., Lavelle E.C., Martin S.J. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
25. Marvie P., Lisbonne M., L'Helgoualc'h A., Rauch M., Turlin B., Preisser L., Bourd-Boittin K., Theret N., Gascan H., Piquet-Pellorce C., Samson M. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 2010, 14:1726-1739.
26. Matta B.M., Lott J.M., Mathews L.R., Liu Q., Rosborough B.R., Blazar B.R., Turnquist H.R. IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J Immunol 2014, 193:4010-4020.
27. Milovanovic M., Volarevic V., Ljujic B., Radosavljevic G., Jovanovic I., Arsenijevic N., Lukic M.L. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype. PLoS One 2012, 7:e45225.
28. Mirchandani A.S., Salmond R.J., Liew F.Y. Interleukin-33 and the function of innate lymphoid cells. Trends Immunol 2012, 33:389-396.
29. O'Connor R.A., Anderton S.M. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol 2008, 193:1-11.
30. Ohno T., Oboki K., Kajiwara N., Morii E., Aozasa K., Flavell R.A., Okumura K., Saito H., Nakae S. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J Immunol 2009, 183:7890-7897.
31. Park H., Jung Y.K., Park O.J., Lee Y.J., Choi J.Y., Choi Y. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J Immunol 2005, 175:7193-7201.
32. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
33. Pomeshchik Y., Kidin I., Korhonen P., Savchenko E., Jaronen M., Lehtonen S., Wojciechowski S., Kanninen K., Koistinaho J., Malm T. Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury. Brain Behav Immun 2014.
34. Rangachari M., Kuchroo V.K. Using EAE to better understand principles of immune function and autoimmune pathology. J Autoimmun 2013, 45:31-39.
35. Reynolds N.D., Lukacs N.W., Long N., Karpus W.J. Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis. J Immunol 2011, 187:2803-2813.
36. Roth S., Zhang S., Chiu J., Wirth E.K., Schweizer U. Development of a serum-free supplement for primary neuron culture reveals the interplay of selenium and vitamin E in neuronal survival. J Trace Elem Med Biol 2010, 24:130-137.
37. Schiering C., Krausgruber T., Chomka A., Frohlich A., Adelmann K., Wohlfert E.A., Pott J., Griseri T., Bollrath J., Hegazy A.N., Harrison O.J., Owens B.M., Lohning M., Belkaid Y., Fallon P.G., Powrie F. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014, 513:564-568.
38. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
39. Schrempf W., Ziemssen T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun Rev 2007, 6:469-475.
40. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
41. Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 2010, 1799:101-113.
42. Sun Y., Chen H., Dai J., Zou H., Gao M., Wu H., Ming B., Lai L., Xiao Y., Xiong P., Xu Y., Gong F., Zheng F. HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis. J Neuroimmunol 2015, 280:29-35.
43. Turnquist H.R., Zhao Z., Rosborough B.R., Liu Q., Castellaneta A., Isse K., Wang Z., Lang M., Stolz D.B., Zheng X.X., Demetris A.J., Liew F.Y., Wood K.J., Thomson A.W. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol 2011, 187:4598-4610.
44. Weiner H.L. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 2008, 255(Suppl 1):3-11.
45. Yasuoka S., Kawanokuchi J., Parajuli B., Jin S., Doi Y., Noda M., Sonobe Y., Takeuchi H., Mizuno T., Suzumura A. Production and functions of IL-33 in the central nervous system. Brain Res 2011, 1385:8-17.
46. Zhang Q., Wang Y. HMG modifications and nuclear function. Biochim Biophys Acta 2010, 1799:28-36.
47. Zhao J., Zhang H., Liu S.B., Han P., Hu S., Li Q., Wang Z.F., Mao-Ying Q.L., Chen H.M., Jiang J.W., Wu G.C., Mi W.L., Wang Y.Q. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice. Neuroscience 2013, 253:172-182.
48. Zhu X., Liu Q., Wang M., Liang M., Yang X., Xu X., Zou H., Qiu J. Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS One 2011, 6:e27081.